From Our Partners
Sunday, June 26, 2022
News on Pathogens and Preparedness
Global Biodefense
  • Featured
  • COVID-19
  • Funding
  • Directory
  • Jobs
  • Events
  • Subscribe
No Result
View All Result
  • Featured
  • COVID-19
  • Funding
  • Directory
  • Jobs
  • Events
  • Subscribe
No Result
View All Result
Global Biodefense
No Result
View All Result
Home Featured News

FDA Medical Countermeasures Initiative Symposium

by Global Biodefense Staff
June 1, 2014
Medical Countermeasures Research for Biodefense

Credit: Shutterstock

MCMi Regulatory Science Symposium PosterFDA’s Medical Countermeasures initiative (MCMi) will host their annual Regulatory Science Symposium this week at FDA Headquarters in Silver Springs, Md.

The goals of the event are to exchange ideas on countermeasure development; highlight work on regulatory science as it applies to developing and advancing medical countermeasures; facilitate innovative directions; and inform stakeholders on related scientific progress and achievements.

Registration for in-person attendance is closed, however the event will also be webcast live and program materials made available at no charge.

Highlighted topics include:

  • Animal Models, Biomarkers & Correlates of Protection
  • Advancing Technologies for Product Characterization
  • Massively parallel sequencing for monitoring genetic variability of seed viruses for influenza vaccine
  • Evaluation of New Technology Multiplex Tests for Detection of Emerging and Blood Borne Pathogens
  • Challenges of a pediatric product in stockpiling: Feasibility studies with a pediatric product of oseltamivir phosphate
  • The influence of device design in cleaning biological and chemical contaminants from reusable medical devices
  • Animal Model Development for Eczema Vaccinatum, a Life-Threatening Smallpox Vaccine Complication
  • Role of natural killer cells against influenza in presence of humanized monoclonal antibodies
  • Systems pharmacology for assessing and understanding drug safety
  • The Pathogenesis and Management of Anthrax Sepsis and Septic Shock: Studies in Small and Large Animal Models
  • Novel nanoparticle and microfluidics approaches for detection of viral pathogens in laboratory based and point-of-care settings
  • Evaluation of New Technology Multiplex Tests for Detection of Emerging and Blood Borne Pathogens
  • Rapid and comprehensive detection of antimicrobial resistance in bacterial pathogens
  • Enabling sequence-based technologies for microbial countermeasures and clinical diagnostics
  • Handheld Automated Notification for Drugs and Immunizations (HANDI)
  • The BARDA Clinical Study Network’s Role in MCM Surveillance
  • Real-time Application for Portable Interactive Devices
  • Harnessing electronic medical records for MCM Surveillance

Please visit the FDA’s MCMi Regulatory Science Symposium website for more information. Follow symposium updates on Twitter by searching #FDARegSci, and follow MCMi at @FDA_MCMi.

From Our Partners
Tags: Animal ModelsAntimicrobialsAntitoxinsAntiviralsASPRBARDABiomarkersBioterrorismChemical DetectionEventsHHSPOC DiagnosticsStrategic National StockpileThermostabilityVaccines

Related Posts

UK Health Security Agency Widens Monkeypox Vaccine Umbrella for Outbreak Control
Medical Countermeasures

UK Health Security Agency Widens Monkeypox Vaccine Umbrella for Outbreak Control

June 21, 2022
Biodefense Industry News
Industry News

Tonix Pharmaceuticals Opens Advanced Development Center for Vaccine Programs

June 20, 2022
Monkeypox Cases Prompt Additional Contracts for Bavarian Nordic Vaccine
Medical Countermeasures

Monkeypox Cases Prompt Additional Contracts for Bavarian Nordic Vaccine

May 30, 2022
Novavax Missed Its Global Moonshot but Is Angling to Win Over mRNA Defectors
Industry News

Novavax Missed Its Global Moonshot but Is Angling to Win Over mRNA Defectors

May 26, 2022
Load More

Latest News

Poliovirus Detected in London Sewage: Response Measures Emphasize Wastewater Surveillance and Vaccination Gaps

Poliovirus Detected in London Sewage: Response Measures Emphasize Wastewater Surveillance and Vaccination Gaps

June 22, 2022
Monkeypox Diagnostics: CDC Authorizes Five Commercial Lab Companies

Monkeypox Diagnostics: CDC Authorizes Five Commercial Lab Companies

June 22, 2022
UK Health Security Agency Widens Monkeypox Vaccine Umbrella for Outbreak Control

UK Health Security Agency Widens Monkeypox Vaccine Umbrella for Outbreak Control

June 21, 2022
Influenza Research

New Way to Identify Influenza A Virus Lights Up When Specific Virus Targets are Present

June 20, 2022

Subscribe

  • About
  • Contact
  • Privacy
  • Subscribe

© 2022 Stemar Media Group LLC

No Result
View All Result
  • Featured
  • COVID-19
  • Funding
  • Directory
  • Jobs
  • Events
  • Subscribe

© 2022 Stemar Media Group LLC